GLP-1 receptor agonist and SGLT2 inhibitor prescribing in people with type 1 diabetes
Li P, Li Z, Staton E, et al.
JAMA. 2024:e2418581.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Li P, Li Z, Staton E, et al.
JAMA. 2024:e2418581.
Leggi
Lipska KJ, Gilliam LK, Lee C, et al.
Diabetes Care. 2024:dc241612.
Leggi
Fan X, Liu Y, Chen X, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
Friis Bryde Nielsen C, Møller Thysen S, Bach Kampmann F, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
Ogurtsova K, Laxy M, Emmert-Fees K, et al.
BMJ Open Diabetes Res Care. 2024;12(5):e004382.
Leggi
Andersen LL, Calatayud J, Núñez-Cortés R, et al. Diabetes Obes Metab. Pub. online 23 Oct 2024. Abstract
Leggi
Zhang L, Shen Y, Liu H, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
Lin B, Coleman RL, Bragg F, et al.
Lancet Diabetes Endocrinol. Pub. online 23 Oct 2024.
Leggi
Herrington WG, Staplin N, Agrawal N, et al. for EMPA-KIDNEY Collaborative Group N Engl J Med. Pub. online 25 Oct 2024. Abstract e full text
Leggi
Sommer J, Borgmann SO, Gontscharuk V, et al.
Lancet Diabetes Endocrinol. Pub. online 24 Oct 2024.
Leggi